Drug Trends has identified, crawled (or ‘scraped’), extracted, categorised and analysed drug listings on cryptomarkets on a regular basis since 1st February 2014. This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month period. The current bulletin focuses on analysis of drug listings on cryptomarkets from October 2024 to September 2025.

An accompanying public online interactive data visualisation is available, allowing viewers to interact with data collected over the total monitoring period.

Key findings

  • From 1st October 2024 to 30th September 2025, 15 cryptomarkets were monitored, of which 10 remained active at the end of the reporting period.
  • The three markets reaching more than 10,000 listings in a snapshot during this period were Archetyp, Drughub and Abacus.
  • In the final month of monitoring, Drughub, Dark Matter, Torzon and Nexus were the largest accessible cryptomarkets.
  • There were 27,630 and 39,288 drug listings per snapshot in October 2024 and September 2025, respectively, with an estimated increase in listings of 2.8% per month. This increase was not statistically significant.
  • Cannabis comprised the greatest percentage of drug listings from October 2024 to September 2025 (25.8%), followed by benzodiazepines (8.0%), MDMA (7.9%), opioids (excluding heroin) (7.4%), cocaine (7.0%), PIEDs/weight loss drugs (6.0%) and meth/amphetamine (illicit; 5.9%).
  • The market share of other psychotropic medicines (e.g., pregabalin, gabapentin, quetiapine) showed the highest rate of increase from 1.8% in October 2024 to 2.8% in September 2025. The greatest significant decrease in market share was observed for cannabis, from 26.2% in October 2024 to 24.9% in September 2025.

Recommended citation

Man, N., Sutherland, R., Barratt, M. J., Bruno, R., Sadaphale, V., & Peacock, A. (2025). Trends in the availability and type of drugs sold on the internet via cryptomarkets, October 2024 - September 2025. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney. Available from: https://doi.org/10.26190/unsworks/31809

Funding and copyright

Drug Trends is supported by funding from the Australian Government Department of Health, Disability and Ageing under the Drug and Alcohol Program.

©NDARC, UNSW SYDNEY 2025 

This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and enquiries concerning reproduction and rights should be addressed to the information manager, NDARC, UNSW Sydney, NSW 2052, Australia via drugtrends@unsw.edu.au.

Date published

27 Nov 2025

Resource type

Drugs and New Technologies (DNeT) bulletins

Research areas